Details for New Drug Application (NDA): 083003
✉ Email this page to a colleague
NDA 083003 describes STILBESTROL, which is a drug marketed by Bristol Myers Squibb and Tablicaps and is included in seven NDAs. Additional details are available on the STILBESTROL profile page.
The generic ingredient in STILBESTROL is diethylstilbestrol. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol profile page.
The generic ingredient in STILBESTROL is diethylstilbestrol. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol profile page.
Summary for 083003
| Tradename: | STILBESTROL |
| Applicant: | Tablicaps |
| Ingredient: | diethylstilbestrol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083003
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
